Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
432 studies found for:    aspirin AND prevention
Show Display Options
Rank Status Study
1 Recruiting Low Dose Aspirin in the Prevention of Preeclampsia in China
Condition: Preeclampsia
Interventions: Drug: Aspirin;   Other: Blank
2 Recruiting Chronotherapy With Low-dose Aspirin for Primary Prevention
Condition: Type 2 Diabetes
Intervention: Drug: aspirin
3 Unknown  Japanese Primary Prevention Project With Aspirin
Conditions: Hypertension;   Hyperlipidemia;   Diabetes Mellitus
Intervention: Drug: Aspirin
4 Unknown  Low Dose Aspirin for the Prevention of Preeclampsia
Condition: Preeclampsia
Interventions: Drug: Aspirin;   Drug: Placebo
5 Completed Japanese Primary Prevention of Atherosclerosis With Aspirin for Diabetes (JPAD) Trial
Conditions: Coronary Disease;   Arteriosclerosis;   Diabetes Mellitus, Type 2
Interventions: Drug: Aspirin;   Drug: No aspirin
6 Active, not recruiting Cilostazol Versus Aspirin for Primary Prevention of Atherosclerotic Events
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Cilostazol;   Drug: Aspirin
7 Completed The Risk of Uncomplicated Peptic Ulcer in a Cohort of Secondary Prevention Aspirin Users
Condition: Uncomplicated Peptic Ulcer
8 Completed Assessment of Low-dose ASA Discontinuation Risk Associated With Concomitant PPI Use During the First Year of ASA Therapy
Condition: Cardiovascular Prevention
Intervention: Drug: Risk of low dose aspirin discontinuation
9 Recruiting A Different Approach to Preventing Thrombosis
Conditions: Venous Thromboembolism;   Pulmonary Embolism
Interventions: Drug: VTE prophylaxis with Enoxaparin 30mg BID;   Drug: VTE prophylaxis with Aspirin 81mg BID
10 Completed
Has Results
Comparative Efficacy & Safety Study of D961H Versus Placebo for the Prevention of Gastric and Duodenal Ulcers With Low-dose Aspirin
Condition: Prevention
Interventions: Drug: Esomeprazole;   Drug: Placebo
11 Unknown  Antiaggregation in Primary Prevention of Vascular Access for Hemodialysis
Condition: Thrombosis
Intervention: Drug: aspirin
12 Terminated Efficacy and Safety of Dorner Tablets and Aspirin for Prevention of Arteriosclerosis Progress in Type 2 Diabetes Mellitus Patients
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Beraprost;   Drug: Aspirin
13 Completed Aspirin/Folate Prevention of Large Bowel Polyps
Conditions: Colorectal Cancer;   Polyps;   Adenomas
Interventions: Drug: Aspirin;   Drug: Folate
14 Recruiting Efficacy and Safety of PMK-S005 in the Prevention of Recurrent Peptic Ulcer in Low-dose Aspirin Users
Condition: Peptic Ulcer
Interventions: Drug: Placebo;   Drug: PMK-S005 1;   Drug: PMK-S005 2;   Drug: PMK-S005 3
15 Unknown  The Safety and Efficacy of Albis®: The Prevention of Aspirin-induced Gastrointestinal Ulcers in Patients
Condition: Patients Taking Low-dose Aspirin
Interventions: Drug: Albis Tab;   Drug: Placebo
16 Recruiting Prevention of Venous Obstruction After Implantation of Cardiac Pacemaker and Defibrillator
Conditions: Complication of Cardiac Defibrillator;   Disorder of Cardiac Pacemaker System;   Venous Occlusion
Interventions: Drug: placebo;   Drug: Aspirin 80 mg daily;   Drug: Clopidogrel 75 mg daily
17 Active, not recruiting Prevention of Pre-eclampsia and SGA by Low-Dose Aspirin in Nulliparous Women With Abnormal First-trimester Uterine Artery Dopplers
Conditions: Pre-eclampsia;   Intra-uterine Growth Restriction
Interventions: Drug: Aspirin;   Drug: Placebo
18 Recruiting Aspirin for Prevention of Postsurgical Recurrence and Metastasis in Asian Colorectal Cancer Patients: a Multi-center Randomized Trial
Condition: Colorectal Cancer
Interventions: Drug: Acetylsalicylic acid (ASA)/aspirin 200 mg daily;   Drug: Acetylsalicylic acid (ASA)/aspirin 100 mg daily;   Drug: Placebo
19 Recruiting Study Comparing Ticagrelor With Aspirin for Prevention of Vascular Events in Patients Undergoing CABG
Conditions: Coronary Artery Disease;   Stable Angina;   Acute Coronary Syndrome
Interventions: Drug: Ticagrelor;   Drug: Aspirin;   Drug: Placebo - Ticagrelor;   Drug: Placebo - Aspirin
20 Completed Prevention of Recurrent Ulcer Bleeding in High-risk Users of Low-dose Aspirin
Condition: Ulcer Hemorrhage

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.